These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27297910)

  • 21. Infliximab for ulcerative colitis.
    Shields CJ; Winter DC
    N Engl J Med; 2006 Mar; 354(13):1424-6; author reply 1424-6. PubMed ID: 16571891
    [No Abstract]   [Full Text] [Related]  

  • 22. Infliximab for ulcerative colitis.
    Reinshagen M
    N Engl J Med; 2006 Mar; 354(13):1424-6; author reply 1424-6. PubMed ID: 16575949
    [No Abstract]   [Full Text] [Related]  

  • 23. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
    Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
    Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of infliximab in Brazilian children and adolescents with Crohn disease and ulcerative colitis according to clinical manifestations, activity indices of inflammatory bowel disease, and corticosteroid use.
    Tiemi J; Komati S; Sdepanian VL
    J Pediatr Gastroenterol Nutr; 2010 Jun; 50(6):628-33. PubMed ID: 20386321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome of infliximab therapy is highly comparable in a Danish and in a Hungarian tertiary center.
    Molnár T; Farkas K; Szepes Z; Nagy F; Wittmann T
    Scand J Gastroenterol; 2011 Feb; 46(2):248-9. PubMed ID: 20923382
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of ulcerative colitis with adalimumab or infliximab: long-term follow-up of a single-centre cohort.
    Gies N; Kroeker KI; Wong K; Fedorak RN
    Aliment Pharmacol Ther; 2010 Aug; 32(4):522-8. PubMed ID: 20500733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of endoscopic assessment in ulcerative colitis in the era of infliximab.
    Daperno M; Sostegni R; Pera A; Rognone D; Rigazio C; Ercole E; Crocellà L; Lavagna A; Rocca R
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S220-4. PubMed ID: 18598992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
    Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
    J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IBD: Golimumab shows promise in treatment of active ulcerative colitis.
    Smith K
    Nat Rev Gastroenterol Hepatol; 2013 Jul; 10(7):386. PubMed ID: 23774769
    [No Abstract]   [Full Text] [Related]  

  • 30. Infliximab in the treatment of steroid-dependent ulcerative colitis.
    Armuzzi A; De Pascalis B; Lupascu A; Fedeli P; Leo D; Mentella MC; Vincenti F; Melina D; Gasbarrini G; Pola P; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2004; 8(5):231-3. PubMed ID: 15638236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis.
    De Vos M; Dewit O; D'Haens G; Baert F; Fontaine F; Vermeire S; Franchimont D; Moreels T; Staessen D; Terriere L; Vander Cruyssen B; Louis E;
    J Crohns Colitis; 2012 Jun; 6(5):557-62. PubMed ID: 22398050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infliximab for pediatric ulcerative colitis: a retrospective Italian multicenter study.
    Cucchiara S; Romeo E; Viola F; Cottone M; Fontana M; Lombardi G; Rutigliano V; de'Angelis GL; Federici T
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S260-4. PubMed ID: 18598998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical treatment and management of severe ulcerative colitis.
    Rizzello F; Campieri M; Tambasco R; Straforini G; Brugnera R; Poggioli G; Gionchetti P
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S280-4. PubMed ID: 18599001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. THE EFFECTIVENESS OF GOLIMUMAB IN SEVERE ULCERATIVE COLITIS WITH EXTRAINTESTINAL MANIFESTATIONS.
    Stepashina ES; Tarasova LV; Busalaeva EI
    Eksp Klin Gastroenterol; 2016 Jul; 12(12):116-119. PubMed ID: 29889434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids.
    Garcia-Planella E; Mañosa M; Van Domselaar M; Gordillo J; Zabana Y; Cabré E; López San Román A; Domènech E
    Dig Liver Dis; 2012 Mar; 44(3):206-10. PubMed ID: 22079262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ulcerative colitis.
    Danese S; Fiocchi C
    N Engl J Med; 2011 Nov; 365(18):1713-25. PubMed ID: 22047562
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of Immunoassays for Measuring Serum Levels of Golimumab and Antibodies Against Golimumab in Ulcerative Colitis: A Retrospective Observational Study.
    Berger AE; Duru G; de Vries A; Marini JC; Aoucheta D; Cornillie F; Nancey S; Detrez I; Gils A; Roblin X; Paul S
    Ther Drug Monit; 2019 Aug; 41(4):459-466. PubMed ID: 30817702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.
    Reinisch W; Sandborn WJ; Hommes DW; D'Haens G; Hanauer S; Schreiber S; Panaccione R; Fedorak RN; Tighe MB; Huang B; Kampman W; Lazar A; Thakkar R
    Gut; 2011 Jun; 60(6):780-7. PubMed ID: 21209123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managing ambulatory ulcerative colitis patients with infliximab: a long term follow-up study in primary gastroenterology centers.
    Tursi A; Elisei W; Picchio M; Penna A; Lecca PG; Forti G; Giorgetti G; Faggiani R; Zampaletta C; Pelecca G; Brandimarte G
    Eur J Intern Med; 2014 Oct; 25(8):757-61. PubMed ID: 25086677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An update on anti-TNF agents in ulcerative colitis.
    Samaan MA; Bagi P; Vande Casteele N; D'Haens GR; Levesque BG
    Gastroenterol Clin North Am; 2014 Sep; 43(3):479-94. PubMed ID: 25110254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.